Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$92,860R01FY2020CANIH
University Of Tx Md Anderson Can Ctr, Houston TX
Investigators
Linked publications, trials & patents
Paper 38019933Paper 37183657Paper 37046782Paper 35216965Paper 35172762Paper 35097226Paper 35045973Paper 34426439Paper 33427657Paper 33108232Paper 33022640Paper 33012364Paper 32943466Paper 32658285Paper 32621758Paper 32609585Paper 32512024Paper 32497113Paper 32396859Paper 32105518Paper 31335325Paper 31271824Paper 31043430
Abstract
Abstract Abstract not requested. This is an NCI Diversity Supplement to Dr. Cullen Taniguchi's Grant# 1R01CA227517-01A1, titled, Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer.
View original record on NIH RePORTER →